Crizotinib/gefitinibDevelopment of resistance: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2017年 / 1676卷 / 1期

关键词：

D O I：

10.1007/s40278-017-38095-5

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：107 / 107

相关论文

共 50 条

[41] AntineoplasticsAcquired crizotinib resistance, constipation and loss of appetite: case report
Reactions Weekly, 2019, 1778 (1) : 50 - 50
[42] CrizotinibDevelopment of crizotinib resistance in metastatic lung cancer: case report
Reactions Weekly, 2018, 1683 (1) : 229 - 229
[43] CrizotinibDevelopment of crizotinib resistance leading to disease progression: case report
Reactions Weekly, 2016, 1621 (1) : 83 - 83
[44] CrizotinibDevelopment of crizotinib-resistance in lung adenocarcinoma: case report
Reactions Weekly, 2017, 1635 (1) : 96 - 96
[45] AntineoplasticsEGFR and KRAS mutations with acquired resistance to crizotinib: case report
Reactions Weekly, 2014, 1515 (1) : 31 - 31
[46] Crizotinib/erlotinib/osimertinibDrug resistance, acne and anorexia: case report
Reactions Weekly, 2021, 1852 (1) : 144 - 144
[47] GefitinibDevelopment of drug resistance in non-small cell lung cancer adenocarcinoma: case report
Reactions Weekly, 2017, 1668 (1) : 192 - 192
[48] GefitinibDevelopment of resistance to gefitinib resulting in transformation of adenocarcinoma to small cell lung carcinoma : case report
Reactions Weekly, 2018, 1698 (1) : 172 - 172
[49] GefitinibDevelopment of resistance in lung adenocarcinoma: 2 case reports
Reactions Weekly, 2015, 1537 (1) : 135 - 135
[50] Erlotinib/gefitinibDevelopment of resistance as a transformation of lung adenocarcinoma to large cell neuroendocrine carcinoma: case report
Reactions Weekly, 2017, 1671 (1) : 185 - 185

← 1 2 3 4 5 →